Multisystem Inflammatory Syndrome In Children
COVID-19 vaccines for young children with rheumatic diseases: What providers need to know
The fight against COVID-19 has shifted drastically since the beginning of 2021. The front lines are no longer nursing homes or retirement communities, but school cafeterias and daycare centers.
Plasma osteopontin may offer 'reliable biomarker' to predict COVID-19, MIS-C severity
Plasma osteopontin levels are significantly higher in children hospitalized with moderate to severe COVID-19 and MIS-C than in those with mild or asymptomatic cases, suggesting a potential biomarker for disease severity, researchers said.
UK researchers report ‘reassuring’ data on long-term MIS-C outcomes
Researchers in the United Kingdom reported “reassuring” data on the 1-year outcomes of dozens of children who had a serious inflammatory syndrome triggered by SARS-CoV-2 infection.
MIS-C, MIS-A cohorts show symptomatic resolution in children, less success in adults
In a cohort of four children and four adults with multisystem inflammatory syndrome, children generally had superior outcomes after discharge, noted a speaker at the 2021 North American Young Rheumatology Investigator Forum.
Long COVID in children: Less frequent and ‘much more poorly understood’
Experts are learning about long COVID, a mysterious syndrome that the CDC describes as “new, returning, or ongoing health problems” that occur 4 or more weeks after a person is initially infected with SARS-CoV-2.
Heart, inflammatory issues resolve rapidly in MIS-C, study finds
Heart and inflammatory issues experienced by pediatric patients hospitalized with multisystem inflammatory syndrome in children mostly resolved within a few months, according to a study published in Pediatrics.
No difference in MIS-C recovery outcomes between IVIG, glucocorticoids, combined therapy
There is no evidence that recovery from multisystem inflammatory syndrome in children differs following treatment with glucocorticoids alone, intravenous immune globulin alone or a combination of the two, according to data.
Neck symptoms a common sign of MIS-C, researchers find
Symptoms of neck inflammation are a common sign of multisystem inflammatory syndrome in children, a serious condition associated with SARS-CoV-2 infection, researchers reported in the Journal of the Pediatric Infectious Diseases Society.
Early intervention key to curb COVID-related inflammatory disease among children
Clinicians and researchers continue to debate the etiology and treatment paradigms for the severe inflammatory syndrome that impacts some children with COVID-19, according to a speaker at the ACR State-of-the-Art Clinical Symposium.
Study provides ‘greater insight’ into MIS-C
Two peaks of multisystem inflammatory syndrome in children — the rare but severe condition associated with SARS-CoV-2 infection — occurred 2 to 5 weeks after peaks of COVID-19 in United States, experts reported in JAMA Pediatrics.